Cellectis Gains Access to Japan Tobacco's Genome Modification Technology | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis Plant Sciences announced today a licensing agreement giving it access to Japan Tobacco's Agrobacterium transformation technology.

The technology, called PureIntro, will be used by Cellectis Plant Sciences, a subsidiary of Cellectis, to modify corn and rice genomes. Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.